Igor Klyubin

9.0k total citations · 1 hit paper
51 papers, 7.4k citations indexed

About

Igor Klyubin is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Igor Klyubin has authored 51 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Physiology, 29 papers in Cellular and Molecular Neuroscience and 23 papers in Molecular Biology. Recurrent topics in Igor Klyubin's work include Alzheimer's disease research and treatments (40 papers), Neuroscience and Neuropharmacology Research (27 papers) and Cholinesterase and Neurodegenerative Diseases (10 papers). Igor Klyubin is often cited by papers focused on Alzheimer's disease research and treatments (40 papers), Neuroscience and Neuropharmacology Research (27 papers) and Cholinesterase and Neurodegenerative Diseases (10 papers). Igor Klyubin collaborates with scholars based in Ireland, United States and China. Igor Klyubin's co-authors include Michael J. Rowan, Dominic M. Walsh, Roger Anwyl, Dennis J. Selkoe, William K. Cullen, Julia V. Fadeeva, Michael S. Wolfe, Neng‐Wei Hu, I. A. Gamaley and Vicki Betts and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Igor Klyubin

50 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

2002 3.5k citations Dominic M. Walsh, Igor Klyubin et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Igor Klyubin Ireland	30	5.8k	3.2k	2.2k	1.5k	1.3k	51	7.4k
Mary Jo LaDu United States	51	7.1k 1.2×	3.8k 1.2×	2.0k 0.9×	1.3k 0.9×	1.9k 1.4×	105	9.6k
Einar M. Sigurdsson United States	43	5.1k 0.9×	2.8k 0.9×	1.4k 0.7×	1.5k 1.0×	2.1k 1.5×	120	7.0k
Pascale N. Lacor United States	29	4.6k 0.8×	2.2k 0.7×	2.0k 0.9×	1.3k 0.9×	1.0k 0.8×	34	6.1k
Ilse Dewachter Belgium	45	5.9k 1.0×	3.9k 1.2×	2.5k 1.2×	1.6k 1.0×	2.0k 1.5×	94	9.3k
Nina E. Shepardson United States	7	4.3k 0.7×	1.9k 0.6×	1.9k 0.9×	1.1k 0.8×	980 0.7×	8	5.4k
Kirsten L. Viola United States	23	8.5k 1.5×	4.0k 1.2×	2.8k 1.3×	2.4k 1.6×	1.6k 1.2×	35	10.2k
Ganesh M. Shankar United States	28	8.1k 1.4×	3.9k 1.2×	3.4k 1.6×	2.2k 1.5×	1.8k 1.4×	87	11.2k
Jeffy P. Jimenez United States	3	5.8k 1.0×	2.8k 0.9×	2.1k 1.0×	1.1k 0.7×	2.2k 1.7×	5	8.4k
Gabriela Peña Argentina	9	5.8k 1.0×	2.9k 0.9×	2.1k 1.0×	1.1k 0.7×	2.2k 1.7×	19	8.6k
William K. Cullen Ireland	16	4.2k 0.7×	2.1k 0.7×	2.0k 0.9×	1.2k 0.8×	900 0.7×	17	5.5k

Countries citing papers authored by Igor Klyubin

Since Specialization

Citations

This map shows the geographic impact of Igor Klyubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Klyubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Klyubin more than expected).

Fields of papers citing papers by Igor Klyubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Klyubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Klyubin. The network helps show where Igor Klyubin may publish in the future.

Co-authorship network of co-authors of Igor Klyubin

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Klyubin. A scholar is included among the top collaborators of Igor Klyubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Klyubin. Igor Klyubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Neng‐Wei, Tomáš Ondrejčák, Igor Klyubin, et al.. (2024). Patient-derived tau and amyloid-β facilitate long-term depression in vivo: role of tumour necrosis factor-α and the integrated stress response. Brain Communications. 6(5). fcae333–fcae333. 3 indexed citations

Ondrejčák, Tomáš, Igor Klyubin, Neng‐Wei Hu, et al.. (2024). Rapidly reversible persistent long-term potentiation inhibition by patient-derived brain tau and amyloid ß proteins. Philosophical Transactions of the Royal Society B Biological Sciences. 379(1906). 20230234–20230234. 3 indexed citations

Yang, Yin, Tomáš Ondrejčák, Neng‐Wei Hu, et al.. (2023). Gamma‐patterned sensory stimulation reverses synaptic plasticity deficits in rat models of early Alzheimer's disease. European Journal of Neuroscience. 58(6). 3402–3411. 6 indexed citations

Klyubin, Igor, Tomáš Ondrejčák, Neng‐Wei Hu, & Michael J. Rowan. (2022). Glucocorticoids, synaptic plasticity and Alzheimer's disease. Current Opinion in Endocrine and Metabolic Research. 25. 100365–100365. 9 indexed citations

Zhang, Yangyang, Yin Yang, Zhengtao Hu, et al.. (2022). Long-Term Depression-Inducing Low Frequency Stimulation Enhances p-Tau181 and p-Tau217 in an Age-Dependent Manner in Live Rats. Journal of Alzheimer s Disease. 89(1). 335–350. 5 indexed citations

Sosulina, Liudmila, Manuel Mittag, Kerstin Hoffmann, et al.. (2021). Hippocampal hyperactivity in a rat model of Alzheimer’s disease. Journal of Neurochemistry. 157(6). 2128–2144. 34 indexed citations

Ondrejčák, Tomáš, Igor Klyubin, Grant T. Corbett, et al.. (2018). Cellular Prion Protein Mediates the Disruption of Hippocampal Synaptic Plasticity by Soluble TauIn Vivo. Journal of Neuroscience. 38(50). 10595–10606. 71 indexed citations

Zhang, Dainan, Yingjie Qi, Igor Klyubin, et al.. (2017). Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies. Neuropharmacology. 121. 231–246. 23 indexed citations

An, Kyongman, Igor Klyubin, Youngkyu Kim, et al.. (2013). Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo. Molecular Brain. 6(1). 47–47. 164 indexed citations

10.

Klyubin, Igor, William K. Cullen, Neng‐Wei Hu, & Michael J. Rowan. (2012). Alzheimer’s disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory. Molecular Brain. 5(1). 25–25. 80 indexed citations

11.

O’Nuallain, Brian, Igor Klyubin, Jessica M. Mc Donald, et al.. (2011). A monoclonal antibody against synthetic Aβ dimer assemblies neutralizes brain‐derived synaptic plasticity‐disrupting Aβ. Journal of Neurochemistry. 119(1). 189–201. 26 indexed citations

12.

Klyubin, Igor, Jessica M. Mc Donald, Alexandra J. Mably, et al.. (2011). Alzheimer's Disease Brain-Derived Amyloid-β-Mediated Inhibition of LTPIn VivoIs Prevented by Immunotargeting Cellular Prion Protein. Journal of Neuroscience. 31(20). 7259–7263. 198 indexed citations

13.

Ondrejčák, Tomáš, et al.. (2009). Alzheimer’s Disease Amyloid β-Protein and Synaptic Function. NeuroMolecular Medicine. 12(1). 13–26. 119 indexed citations

14.

Vollmayr, Barbara, et al.. (2009). Persistent inhibition of hippocampal long‐term potentiation in vivo by learned helplessness stress. Hippocampus. 20(6). 758–767. 35 indexed citations

15.

Wang, Qinwen, Igor Klyubin, Sarah Wright, et al.. (2007). αv integrins mediate beta-amyloid induced inhibition of long-term potentiation. Neurobiology of Aging. 29(10). 1485–1493. 36 indexed citations

16.

Klyubin, Igor, Dominic M. Walsh, Cynthia A. Lemere, et al.. (2005). Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo. Nature Medicine. 11(5). 556–561. 405 indexed citations

17.

Klyubin, Igor, Dominic M. Walsh, William K. Cullen, et al.. (2004). Soluble Arctic amyloid β protein inhibits hippocampal long‐term potentiation in vivo. European Journal of Neuroscience. 19(10). 2839–2846. 96 indexed citations

18.

Walsh, Dominic M., Igor Klyubin, Julia V. Fadeeva, et al.. (2002). Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416(6880). 535–539. 3524 indexed citations breakdown →

19.

Gamaley, I. A., et al.. (1999). Cell-cycle-dependent changes in membrane potential of L-929 cells caused by the effect of hydrogen peroxide. Pflügers Archiv - European Journal of Physiology. 438(1). 113–115. 2 indexed citations

20.

Gamaley, I. A. & Igor Klyubin. (1999). Roles of Reactive Oxygen Species: Signaling and Regulation of Cellular Functions. International review of cytology. 188. 203–255. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact